Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wilson Martin, holds the title of General Counsel at ROCKET PHARMACEUTICALS, INC..
On 2026-11-18, the insider transacted 677 shares.The shares were transacted at a weighted average price of $2.18 per share, resulting in a total market-relevant value of $1K.
Wilson Martin (General Counsel) sold $1K of $RCKT
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.